Over the past several decades, cancer therapy has evolved from conventional chemotherapy to targeted agents, immunotherapy, and other novel approaches. To help APPs and other clinicians navigate how these therapies are used to treat solid tumors and hematologic malignancies, Horizon CME has developed “Cancer Therapy Review for Advanced Practice Providers”. In this virtual two-day program, clinicians will gain understanding of the various classes of cancer therapy, their mechanisms of action, safety profiles, and applicability in hematologic malignancies and solid tumors. Participation in this program will provide APPs with the practical knowledge they need to provide support and care for patients with cancer.